Cymbiotika's Liposomal NAD+ is a multi-ingredient oral packet marketed for cellular function and healthy aging. The checked page describes a formula involving NAD-related ingredients alongside apigenin, TMG, niacin, and Lutemax.
A result attributed to one added ingredient is not automatically evidence that NAD caused it. This is particularly important when the page discusses both cellular metabolism and skin appearance.
Cymbiotika's Liposomal NAD+ is a multi-ingredient oral packet marketed for cellular function and healthy aging. The checked page describes a formula involving NAD-related ingredients alongside apigenin, TMG, niacin, and Lutemax.
Why the whole formula matters
The product combines several components rather than offering a direct comparison with an NR-only capsule. Read the current panel for amounts and the full list of inactive ingredients. The page's narrative about replenishing or recycling NAD explains a proposed mechanism; it does not establish the size of a health benefit from the finished packet.
What do the skin-related percentages mean?
The manufacturer connects some appearance claims to Lutemax, a lutein-and-zeaxanthin ingredient. A study of that component should not be described as a trial showing that NAD alone improves skin. Ask whether any finished-product study isolates the relevant contribution and whether its participants and methods match the claim you care about.
Price and serving comparison
The checked page displayed a $77 one-time price and $53.90 subscription price for an advertised one-month supply. Promotions and bundle selections may differ. Confirm the number of packets, renewal amount, and interval at checkout; do not rely on a displayed cost-per-serving figure without matching its selected offer.
What does third-party testing establish?
The manufacturer describes contaminant screening and quality testing. Ask for the current report and which lot it covers. A purity award or contaminant panel cannot by itself establish absorption superiority or longer life. Our liposomal guide separates those types of evidence.
Our assessment
The packet format may be a practical preference, but the multi-ingredient design makes causal claims harder to interpret. Compare Rho's direct-NAD liquid and an identifiable NR capsule by ingredient first. An endorsement, including a celebrity or wellness personality's approval, does not replace a controlled trial of the finished product or a review of whether its formula fits your situation.
Sources & reading notes
Primary sources checked September 18, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- Cymbiotika: Liposomal NAD+ Manufacturer describes a multi-ingredient packet; quality and benefit claims require separate evaluation.
- Martens et al. (2018): randomized oral NR crossover trial Short-term human biomarker and tolerability study; not a lifespan trial.
- FDA: questions and answers on dietary supplements Regulatory categories and limits of premarket review.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.